Possible association between genetic polymorphisms in transforming growth factor β receptors, serum transforming growth factor β1 concentration and abdominal aortic aneurysm

British Journal of Surgery

Volumn 96, Issue 6, 2009, Pages 628-632

  Golledge, J ^a   Clancy, P ^a   Jones, G T ^d   Cooper, M ^b   Palmer, L J ^b   Van Rij, A M ^d   Norman, P E ^c  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 66749149455     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6633     Document Type: Article

References (20)

1. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-121.
2. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl JMed 2006; 355: 788-798. (Pubitemid 44285584)
3. Pannu H, Fadulu VT, Chang J, Lafont A, Hasham SN, Sparks E et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005; 112: 513-520. (Pubitemid 41060791)
4. Nataatmadja M, West J, West M. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 2006; 114: I371-377. (Pubitemid 44297178)
5. Hasham SN, Guo DC, Milewicz DM. Genetic basis of thoracic aortic aneurysms and dissections. Curr Opin Cardiol 2002; 17: 677-683. (Pubitemid 36084268)
6. Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006; 26: 2605-2613. (Pubitemid 44777272)
7. Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study. Circulation 2007; 116: 2275-2279. (Pubitemid 350100333)
8. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort profile: the Health in Men Study (HIMS). Int J Epidemiol 2009; 38: 48-52.
9. Jones GT, Thompson AR, van Bockxmeer FM, Hafez H, Cooper JA, Golledge J et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 2008; 28: 764-770.
10. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 2004; 110: 862-866. (Pubitemid 39099314)
11. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 42: 361-372.
12. Dai J, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P et al. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation 2005; 112: 1008-1015. (Pubitemid 41170269)
13. Matt P, Habashi J, Carrel T, Cameron DE, Van Eyk JE, Dietz HC. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg 2008; 135: 389-394.
14. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990; 137: 1199-1213.
15. Forester ND, Cruickshank SM, Scott DJ, Carding SR. Functional characterization of T cells in abdominal aortic aneurysms. Immunology 2005; 115: 262-270. (Pubitemid 40733413)
16. He R, Guo DC, Sun W, Papke CL, Duraisamy S, Estrera AL et al. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg 2008; 136: 922-999.
17. Thompson AR, Drenos F, Hafez H, Humphries SE. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg 2008; 35: 19-30. (Pubitemid 350235228)
18. Ito S, Akutsu K, Tamori Y, Sakamoto S, Yoshimuta T, Hashimoto H et al. Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol 2008; 101: 696-699.
19. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007; 27: 1248-1258. (Pubitemid 46809412)
20. Molin DG, Poelmann RE, DeRuiter MC, Azhar M, Doetschman T, Gittenberger-de Groot AC. Transforming growth factor beta-SMAD2 signalling regulates aortic arch innervation and development. Circ Res 2004; 95: 1109-1117. (Pubitemid 39557898)